利培酮联合经颅磁刺激对精神分裂症患者临床症状的影响

doi:10.3760/cma.j.cn441417-20250307-20023

摘要/Abstract

摘要：

目的　分析利培酮联合经颅磁刺激对精神分裂症患者临床症状的影响。方法　采用前瞻性研究。选取安康市中心医院2021年6月至2023年12月收治的90例精神分裂症患者，按随机数字表法分为常规组和研究组，各45例。常规组：男23例，女22例，年龄（40.04±4.93）岁，病程（4.24±1.12）年；采取口服利培酮治疗（第1天剂量为1 mg/次，2次/d；第3天剂量加至3 mg/d；第5天加至4 mg/d；2周内调整完成后不再更改）。研究组：男21例，女24例，年龄（40.28±4.76）岁，病程（4.28±1.16）年；在常规组基础上联合频率10 Hz的经颅磁刺激治疗。两组均干预1个月。比较两组干预前后认知功能、临床症状与疗效。统计学方法采用χ²检验、t检验。结果　干预后，研究组韦氏记忆量表（WMS）量表评分高于常规组［（120.49±10.26）分比（115.74±10.04）分］，阳性与阴性症状量表（PANSS）评分低于常规组［（109.29±10.27）分比（115.38±10.76）分］，差异均有统计学意义（t=2.220、2.747，均P<0.05）。干预后，研究组治疗总有效率高于常规组［91.11%（41/45）比75.56%（34/45）］，差异有统计学意义（t=3.920，P<0.05）。结论　利培酮联合经颅磁刺激治疗有利于促进精神分裂症患者认知功能恢复，缓解相关临床症状，提高临床疗效，具有一定推广价值。

关键词:

利培酮, 经颅磁刺激, 精神分裂症, 认知功能

Abstract:

Objective　Analysis of the impact of risperidone combined with transcranial magnetic stimulation on the clinical symptoms of patients with schizophrenia. Methods　A prospective study was adopted. A total of 90 patients with schizophrenia who were admitted to Ankang Central Hospital from June 2021 to December 2023 were selected. They were divided into the conventional group and the research group according to the random number table method, with 45 cases in each group.Control group: 23 males and 22 females, with an age of (40.04±4.93) years and an disease duration of (4.24±1.12) years.Oral risperidone treatment was adopted (the dose on the first day was 1 mg per time, twice a day; the dose was increased to 3 mg per day on the third day; it was increased to 4 mg per day on the fifth day; after two weeks of adjustment, the dosage was finalized and no further changes were made). Research group: 21 males and 24 females, with an average age of (40.28±4.76) years and an average disease duration of (4.28±1.16) years. In addition to the conventional treatment, transcranial magnetic stimulation at a frequency of 10 Hz was combined.Both groups were intervened for one month.Compare the cognitive functions, clinical symptoms and therapeutic effects of the two groups before and after the intervention.Statistical methods employed were the χ² test and the t test. Results　After the intervention, the score of the Wechsler Memory Scale (WMS) in the study group was higher than that in the control group [(120.49±10.26) points vs. (115.74±10.04) points], and the score of the Positive and Negative Syndrome Scale (PANSS) was lower than that in the control group [(109.29±10.27) points vs. (115.38±10.76) points], and the differences were statistically significant (t=2.220 and 2.747; both P<0.05).After the intervention, the total effective rate of treatment in the study group was higher than that in the control group [91.11% (41/45) vs. 75.56% (34/45)], and the difference was statistically significant (t=3.920, P<0.05). Conclusion　Risperidone combined with transcranial magnetic stimulation is beneficial for promoting the recovery of cognitive function in patients with schizophrenia, alleviating related clinical symptoms, and improving clinical efficacy. It has certain promotional value.

Key words:

Risperidone, Transcranial magnetic stimulation, Schizophrenia, Cognitive function

张贻波李猛杰黄海亮.

利培酮联合经颅磁刺激对精神分裂症患者临床症状的影响 [J]. 国际医药卫生导报, 2025, 31(20): 3455-3459.

Zhang Yibo, Li Mengjie, Huang Hailiang.

The effect of risperidone combined with transcranial magnetic stimulation on clinical symptoms in patients with schizophrenia [J]. International Medicine and Health Guidance News, 2025, 31(20): 3455-3459.

参考文献

[1] de Pinho LMG, Sequeira CADC, Sampaio FMC,et al. A randomized controlled trial to evaluate the efficacy of metacognitive training for people with schizophrenia applied by mental health nurses: Study protocol[J]. J Adv Nurs, 2020, 76(1):356-363. DOI: 10.1111/jan.14240. Epub 2019 Nov 4. PMID: 31642084.
[2] 林荫,陈圣丽,罗海东. 重复经颅磁刺激联合利培酮预防老年精神分裂症复发和改善患者认知功能的效果[J]. 中国老年学杂志,2023,43(24):5958-5960. DOI:10.3969/j.issn.1005-9202.2023.24.020.
[3] 申变红,张开元,汪程鹏,等. 双背侧前额叶低频重复经颅磁刺激对缓解期精神分裂症患者认知功能的影响[J]. 浙江医学,2023,45(23):2518-2521,2530. DOI:10.12056/j.issn.1006-2785.2023.45.23.2023-135.
[4] 赵婧,郭银淼,李梦楠,等. θ短阵快速脉冲重复经颅磁刺激对老年慢性精神分裂症阴性症状及认知功能的影响[J]. 中华行为医学与脑科学杂志,2021,30(7):577-583. DOI:10.3760/cma.j.cn371468-20210423-00227.
[5] 石川,刘哲宁,于欣,等. 欧洲精神病学协会«精神分裂症认知功能损害评估指引»解读[J]. 中华精神科杂志,2024,57(12):783-788. DOI:10.3760/cma.j.cn113661-20240718-00242.
[6] Karashima S, Nakamizo A, Arimura K,et al. Intellectual function and memory in children with moyamoya disease: relationship between Wechsler Intelligence Scale and benton visual retention test scores and regional cerebral blood flow[J]. J Neurosurg Pediatr, 2024, 33(4):301-306. DOI: 10.3171/2023.11.PEDS23317. PMID: 38277655.
[7] 白春明,郭剑,李满桂. 精神分裂症患者脑脊液和血浆中溶血磷脂酸水平与阳性和阴性症状量表评分间的相关性分析[J]. 中华保健医学杂志,2020,22(1):42-44. DOI:10.3969/j.issn.1674-3245.2020.01.012.
[8] Nair N, Taksal A, Mohan G,et al. Patient-reported outcome measures in early psychosis: evaluating the psychometric properties of the single-item self-reported health and self-reported mental health measures in Chennai, India and Montreal, Canada[J]. Early Interv Psychiatry, 2024, 18(7):524-534. DOI: 10.1111/eip.13485.
[9] 成加林,牛军涛,何杰,等. 齐拉西酮联合改良电休克治疗首发精神分裂症患者的疗效及对血清p-mTOR和IL-18水平的影响[J]. 中国现代医学杂志,2020,30(17):72-76. DOI:10.3969/j.issn.1005-8982.2020.17.014.
[10] 高镇松,陈泽华,徐丽缄,等. 社区精神分裂症患者、家属和精神病防治人员对疾病认知、治疗依从性及社区服务评价的质性研究[J]. 中华行为医学与脑科学杂志,2020,29(3):271-276. DOI:10.3760/cma.j.cn371468-20200117-00995.
[11] 余爱花,朱玉星,罗丹,等. 高压氧联合石杉碱甲在辅助精神分裂症患者无抽搐电休克治疗中的应用[J]. 中华航海医学与高气压医学杂志,2024,31(3):322-325. DOI:10.3760/cma.j.cn311847-20230104-00002.
[12] 金志兴,赵静,朱殿明,等. 奥氮平联合越鞠丸治疗以阴性症状为主的精神分裂症的疗效[J]. 川北医学院学报,2024,39(12):1655-1658. DOI:10.3969/j.issn.1005-3697.2024.12.016.
[13] 杜颖,岑芷依,彭欐涵,等. 重复经颅磁刺激联合计算机辅助治疗对脑卒中后失语病人语言功能的影响研究[J]. 护理研究,2021,35(8):1394-1397. DOI:10.12102/j.issn.1009-6493.2021.08.013.
[14] 江良昌,张久玲,杨仁锦. 利培酮联合阿立哌唑治疗精神分裂症的临床疗效及对患者记忆功能的影响[J]. 保健医学研究与实践,2023,20(z2):123-125. DOI:10.11986/j.issn.1673-873X.2023.S2.34.
[15] 胡怡,黄朝红,邱尔仙,等. 舒肝颗粒与阿立哌唑对女性首发精神分裂症服药所致高催乳素血症患者认知功能的影响[J]. 中国医药,2021,16(12):1818-1822. DOI:10.3760/j.issn.1673-4777.2021.12.014.
[16] 倪小红,吕衍文,蔡炜琼,等.疏肝开窍针刺法联合利培酮对首发精神分裂患者的临床疗效分析[J].国际精神病学杂志,2021,48(5):832-835.DOI:10.13479/j.cnki.jip.2021.05.018.
[17] 吉莉,周蓓,吕翔,等. 重复经颅磁刺激联合励-协夫曼言语治疗对脑卒中后吞咽障碍联合嗓音障碍患者嗓音质量的影响研究[J]. 实用心脑肺血管病杂志,2024,32(11):120-124. DOI:10.12114/j.issn.1008-5971.2024.00.271.
[18] 叶丹弟,阎同军,胡江燕,等. 精神分裂症阴性症状重复经颅磁刺激康复治疗效果研究[J]. 临床精神医学杂志,2024,34(3):215-218. DOI:10.3969/j.issn.1005-3220.2024.03.012.
[19] 陈天意,介勇,汪作为,等. 双频加速重复经颅磁刺激治疗精神分裂症阴性症状的随机双盲对照研究[J]. 临床精神医学杂志,2023,33(2):137-141. DOI:10.3969/j.issn.1005-3220.2023.02.012.
[20] 南慧,冯艳亭,周丽,等. 多感官刺激联合重复经颅磁刺激在儿童语言发育迟缓/障碍中的应用研究[J]. 国际医药卫生导报,2023,29(19):2683-2687. DOI:10.3760/cma.j.issn.1007-1245.2023.19.005.
[21] 庞兰,李佩璠,朱晓岗,等. 深部经颅磁刺激联合草酸艾司西酞普兰治疗抑郁症的疗效:一项随机对照试验[J]. 中国全科医学,2024,27(17):2098-2103. DOI:10.12114/j.issn.1007-9572.2023.0555.
[22] 刘欣甜,王甜甜,吕亚婷,等. 重复经颅磁刺激治疗脑卒中后抑郁的研究进展[J]. 中华老年心脑血管病杂志,2024,26(2):238-240. DOI:10.3969/j.issn.1009-0126.2024.02.030.
[23] 禄熠行,孙晓龙,郗宵,等. 高频重复经颅磁刺激治疗脊髓损伤后神经病理性疼痛疗效的影响因素分析[J]. 中华物理医学与康复杂志,2025,47(3):226-231. DOI:10.3760/cma.j.cn421666-20240828-00698.
[24] 张燕,杜程程,白亮亭,等. 高压氧联合高频重复经颅磁刺激治疗脑卒中后吞咽障碍47例疗效观察[J]. 中华航海医学与高气压医学杂志,2025,32(1):1-5. DOI:10.3760/cma.j.cn311847-20240516-00123.
[25] 孙莎莎,李香,郭萍,等. 高压氧辅助高频重复经颅磁刺激治疗对帕金森病患者运动诱发电位及运动功能的影响[J]. 中华航海医学与高气压医学杂志,2023,30(6):736-740. DOI:10.3760/cma.j.cn311847-20230601-00136.